Corrigendum to 'Patient-Reported Outcomes With Consolidation Durvalumab Versus Placebo After Concurrent Chemoradiotherapy in Limited-Stage SCLC: Results From the Phase 3 ADRIATIC Trial' [Journal of Thoracic Oncology volume 21 issue 6 (2026) 103564].

Authors

Silvia Novello, David R Spigel, Jian Fang, Yuanbin Chen, Yoshitaka Zenke, Ki Hyeong Lee, Alejandro Navarro, Eva Lotte Buchmeier, John Wen-Cheng Chang, Yoshimasa Shiraishi, Mustafa Özgüroğlu, Yu Jung Kim, Nguyen Thi Thai Hoa, Sayed M S Hashemi, Anne C Chiang, Ralph Turner, Helen Mann, Yuka Olivo, Haiyi Jiang, Suresh Senan

Published in

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. Pages 103964. Jun 05, 2026. Epub Jun 05, 2026.

PMID:
42340283
Bibliographic data and abstract were imported from PubMed on 24 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.